Head-to-head for women
Henry Meds vs REMEVi
Henry Meds and REMEVi both offer GLP-1 telehealth to women, but they make different trade-offs on PCOS and hormonal suitability, clinical oversight, price and access. Here they are side-by-side on the Luna Fit Score — our women's-health rubric.
Henry Meds
Ranked #39 for women · Grade B
Luna Fit
Best for: Women who want a simple, well-established flat-fee compounded program and don't mind paying more for the brand.
Visit Henry MedsREMEVi
Higher scoreRanked #31 for women · Grade B
Luna Fit
Best for: Women who prioritize LegitScript accreditation and nationwide access, and don't mind mid-to-higher pricing.
Visit REMEViThe verdict for women
REMEVi edges out Henry Meds on the Luna Fit Score, 85 to 83 (B vs B). Women who prioritize LegitScript accreditation and nationwide access, and don't mind mid-to-higher pricing. The reasoning behind that number is in the REMEVi scorecard.
Henry Meds is still a genuine option — a flat-fee compounded pioneer — a simple, well-known model, but priced at the higher end now with no hormone-specific angle. Weigh the six women's-health factors below against your own priorities; our Henry Meds write-up for women goes through each of them, and if neither of these two is the one, the full field we rank against Henry Meds widens the field.
Side-by-side on the six factors
Both providers scored on the same women's-health rubric — the higher side on each factor is marked. See the methodology.
Price, access & features
| Detail | Henry Meds | REMEVi |
|---|---|---|
| Luna Fit Score | 83/100 · B | 85/100 · B |
| Overall rank | #39 | #31 |
| Semaglutide | $249/mo | $199/mo |
| Tirzepatide | $349/mo | $269/mo |
| Coverage | Multi-state | All 50 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Luna Fit
Henry Meds
Ranked #39 · Grade B
What we like
- Simple flat-fee model with both molecules
- Well-established, widely recognized brand
- Clear, predictable billing
The caveats
- Higher pricing than many newer entrants
- Compounded only, no hormone-specific framing
Luna Fit
REMEVi
Ranked #31 · Grade B
What we like
- LegitScript-accredited and available in all 50 states
- Both molecules disclosed, tirzepatide for insulin-resistant PCOS
- Clear, predictable pricing
The caveats
- Higher-end pricing — $199 semaglutide, $269 tirzepatide
- No oral or brand-name option; general program without hormone specialization
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. Pricing, states and verification reflect each provider's public disclosures at last review; the Luna Fit Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.
More head-to-heads
Neither Henry Meds nor REMEVi is only worth comparing with the other. Henry Meds is also written up against Ondra Health, 5 points apart on the Luna Fit Score — see the Henry Meds–Ondra Health head-to-head. REMEVi is also written up against CoreAge Rx, 8 points apart — see the REMEVi–CoreAge Rx head-to-head.
- Henry Meds vs CoreAge Rx
- Henry Meds vs Enhance MD
- Henry Meds vs yourEra
- REMEVi vs Sesame Care
- REMEVi vs HealthRX
- REMEVi vs MadeMed
Or browse the full comparison hub.